Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study

BACKGROUND: Multiple myeloma (MM) is associated with a high risk of thrombosis, particularly during the first months of treatment including immunomodulatory drugs (IMiDs). There is no consensus on prevention of thromboembolic risk in patients with de novo MM, and identification of patients requiring...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Res Pract Thromb Haemost
Main Authors: Chalayer, Emilie, Tardy‐Poncet, Brigitte, Karlin, Lionel, Chapelle, Céline, Montmartin, Aurélie, Piot, Michèle, Guyotat, Denis, Collet, Philippe, Lecompte, Thomas, Tardy, Bernard
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Articles: Thrombosis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332829/
https://ncbi.nlm.nih.gov/pubmed/30656281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12161
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki